Antidotes

Antidotes

 

Dimercaptosuccinic acid,2418-14-6
Dimercaptosuccinic acid
Dimercaptosuccinic acid,2418-14-6
CAS
2418-14-6
Molecular Formula
C4H6O4S2 
Molecular Weight
182.219
Systematic Name
Succinic acid, 2,3-dimercapto- ; DMSA
Assay
99%
Certificate of analysis
Dimercaptosuccinic acid,2418-14-6
View via PDF file
Dimercaptosuccinic acid,2418-14-6
Specification
Items
Specification
Test result
Appearance
White Crystalline Powder
Complies
Melting Point
>190℃
196~197℃
pH
2.4 to 2.6
2.5
Heavy metals
Not more than 10ppm
Complies
Reside on ignition
Not more than 0.1%
Complies
Loss on drying
Not more than 0.5%
0.32%
Assay
>98.5%
99.2%
Contact us for more information
Chemical information
Compound Name*
CAS No. "N/A" if the CAS not available*
Quantity*
Contact information
Contact person*
Email Address *
Tel No.*
Company or Organization Name*
Shipping Address*
Country
Remarks

<Privacy policy: the contact information will be only used for this business contact>

Packing
Dimercaptosuccinic acid,2418-14-6
Packing 1
10g
Packing 2
100g
Packing 3
500g
   
   
Bulk request
sales@lanospharma.com
Related Antidotes
DMPS [HOT]
DMSA [HOT]
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of
Lanos' Pharmaceutical Co.,LTD ’s product(Dimercaptosuccinic acid,2418-14-6,99%,Antidotes).
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.